Next Gen Sequencing - The Online Scientific Community

Courtagen Introduces Genomic Profiling Services in their Newly Licensed CLIA Lab
Friday, March 30, 2012
Lead genetic tests utilize next-generation sequencing and proprietary Ziphyr™ bioinformatics platform to diagnose mitochondrial disease.

Ambry Genetics Introduces "First-Step Exome™" Sequencing Test
Thursday, March 29, 2012
Affordable test will report on mutations in all HGMD-defined genes as part of industry-first tiered approach to diagnostic exome testing.

Agilent Adds New Integrated Biology Capabilities to Bioinformatics Suite
Wednesday, March 28, 2012
GeneSpring now performs pathway-level multi-omics, next-gen sequencing analysis.

Lineagen Applies Affymetrix' GeneChip® Technology to Next-Generation FirstStepDx® Service
Wednesday, March 28, 2012
Service for individuals with developmental delay and autism spectrum disorders.

Epigentek Releases Its Next Low-Cost, High-Throughput Sonication Devices for DNA and Chromatin Shearing
Monday, March 26, 2012
The EpiSonic(TM) Multi-Functional Bioprocessor 1100 (EpiSonic(TM) 1100) is an upgrade from its 1000 model predecessor.

SPRIworks HT Automates Sample Preparation for Next-generation Sequencing, Showcased at Pittcon 2012
Thursday, March 22, 2012
Processes 96 fragment libraries in less than six hours with per-well size selection.

IDT Oligos Used to Increase Efficiency of Detecting Genetic Variation
Tuesday, March 20, 2012
IDT’s DECODED newsletter discusses research carried out at the Hubrecht Institute.

Agilent Technologies Introduces Next-Generation Fluorescent In Situ Hybridization Assays for Molecular Analysis
Wednesday, March 07, 2012
Agilent Technologies Inc. introduced Agilent SureFISH probes, the next generation of fluorescent in situ hybridization (FISH) assays, delivering a comprehensive menu of the industry’s highest resolution probes for a wide range of molecular analysis applications.

Eureka Genomics Launches 16S Metagenomics Next Generation Sequencing & Bioinformatics Services
Thursday, February 16, 2012
Company has teamed with Robert C. Edgar, PhD to develop state-of-the-art proprietary algorithms that allow EG to offer a flexible, cost-effective 16S metagenomic analysis service.

<<	4 5 6 7 8 9 10	>>
Showing Results 61 - 70 of 110

Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.

Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.

Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.